<DOC>
	<DOC>NCT02844803</DOC>
	<brief_summary>The study is a pilot trial to investigate the effect of Metformin and S. Baicalensis Combination Therapy in Type 2 Diabetes Mellitus Patients.</brief_summary>
	<brief_title>Study of Metformin and S. Baicalensis Combination Therapy in Type 2 Diabetes Mellitus Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Diagnosed as a diabetes mellitus patient at least 3 months ago on screening Treated with metformin of â‰¥ 500 mg/day over 3 months on screening Fasting glucose level of 110~180 mg/dl or HbA1c of 7.0~9.0% on screening With acute or chronic inflammation Treated with systemic corticosteroids within 4 weeks prior to the first administration of study medication With heart failure, myocardial infarction, stroke, or other acute severe cardiovascular diseases With acute or chronic renal failure or nephrotic syndrome With impaired hepatic function. Drug or Alcoholic abuser Pregnant or nursing woman</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>